Global /South Korea /Healthcare /Drug Manufacturers - General /004310
chevron_leftBack
Hyundai Pharmaceutical Co., Ltd. logo

Hyundai Pharmaceutical Co., Ltd.

004310
KRX: 004310 Delayed
8,630KRW -3.1%
5.65 USD
As of 9 June 2026, Hyundai Pharmaceutical Co., Ltd. has a market cap of $161.49M USD, ranking #22535 globally and #948 in South Korea. It ranks #2027 in the Healthcare sector, and #727 in the Drug Manufacturers - General industry.
Global Rank
22535
Country Rank
948
Sector Rank
2027
Industry Rank
727
Key Stats
Market Cap
$161.49MUSD
246.61B KRW
Revenue (TTM)
$70.81MUSD
108.14B KRW
EBITDA (TTM)
$2.81MUSD
4.3B KRW
Net Income (TTM)
$926.54KUSD
1.41B KRW
EBITDA Margin
4%
Profit Margin
1.3%
PE Ratio
147.7
PS Ratio
2.3
PB Ratio
2.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Sang-Jun Lee open_in_new
Employees
393
Founded
1965
Website
hyundaipharm.co.kr open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-3.1% 5.5% -3.7% -25% 131% 161%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
004310
현대약품(주)
ISIN: KR7004310009
Shares Out.:
26.136M1 Shares Float: 24.251M2
TV:
SA:
YF:
GF:
BA:
MS:
8,630 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Hyundai Pharmaceutical Co., Ltd.

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive system, endocrine system, expectorants, eye tonic and vitamins, gynaecolog antifungals, gynaecologic antiseptics, hemostatics, labour inhibitors, leukotriene modulator, narcotic analgesics, NSAIDs, oestrogens, ophthalmic products, OTH.sex horm and similar, SERMS, systemic hormonal contraceptives, urogenital system depilatory, uterotonic products, various alimentary tract and metabolism products, vitamins, acne, allergy, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial and antivirus, arthritis, contraceptives, dermatological agent, diagnostic reagent, gastrointestinal disorder and digestant, lip care, nutrition, ophthalmic product, respiratory, urogenital system, wound healing, and others. Hyundai Pharmaceutical Co., Ltd. was founded in 1965 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)
Name
Market Cap diff.
PE
$9.11B
13.91T KRW
6K%
-
$6.75B
10.3T KRW
4K%
1958.1
$5.22B
7.97T KRW
3K%
29.9
298380
$4.94B
7.55T KRW
3K%
-
000100
$4.53B
6.92T KRW
3K%
35.9
$4.43B
6.76T KRW
3K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
472K%
38.1
JNJ
$547.28B
339K%
26.4
ABBV
$360.63B
223K%
97.4
$322.98B
256.25B CHF
200K%
19.9
AZN
$288.68B
215.59B GBP
179K%
27.6
NOVN
$275.9B
218.9B CHF
171K%
20.5
chevron_leftBack